Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2416281, 4 pages
https://doi.org/10.1155/2017/2416281
Research Article

Prevalence of Diabetes Type 2 in Hepatitis C Infected Patients in Kpk, Pakistan

1Department of Biotechnology, Bacha Khan University, Charsadda, Pakistan
2Department of Agriculture, Abdul Wali Khan University Mardan, Mardan, Pakistan
3Coconut Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wenchang City, Hainan 571339, China
4Department of Biotechnology, Abdul Wali Khan University Mardan, Mardan, Pakistan
5Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
6Department of Plant Breeding and Genetics, Bacha Khan University, Charsadda, Pakistan
7Department of Agriculture, University of Swabi, Ambar, Pakistan
8Department of Pathology, The University of Agriculture, Peshawar, Pakistan
9Institute of Biomedical Sciences, East China Normal University, Shanghai, China

Correspondence should be addressed to Amjad Iqbal; moc.oohay@741labqidajma

Received 11 October 2016; Revised 20 December 2016; Accepted 22 December 2016; Published 4 April 2017

Academic Editor: Giulia Morsica

Copyright © 2017 Ghani Ur Rehman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Ghany, D. B. Strader, D. L. Thomas, and L. B. Seeff, “Diagnosis, management, and treatment of hepatitis C: an update,” Hepatology, vol. 49, no. 4, pp. 1335–1374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Medhat, M. Shehata, L. S. Magder et al., “Hepatitis C in a community in Upper Egypt: risk factors for infection,” American Journal of Tropical Medicine and Hygiene, vol. 66, no. 5, pp. 633–638, 2002. View at Google Scholar · View at Scopus
  3. C. D. Williams, J. Stengel, M. I. Asike et al., “Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study,” Gastroenterology, vol. 140, no. 1, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Lavanchy, “The global burden of hepatitis C,” Liver International, vol. 29, no. 1, pp. 74–81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. E. Gordon, E. M. Balk, B. N. Becker et al., “KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD,” American Journal of Kidney Diseases, vol. 52, no. 5, pp. 811–825, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 36, supplement 1, pp. S67–S74, 2012. View at Publisher · View at Google Scholar
  7. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 37, supplement 1, pp. S81–S90, 2014. View at Google Scholar
  8. W. Qidwai and T. Ashfaq, “Imminent epidemic of diabetes mellitus in Pakistan: issues and challenges for health care providers,” Journal of Liaquat University of Medical and Health Sciences, vol. 9, no. 3, pp. 112–113, 2010. View at Google Scholar · View at Scopus
  9. A. S. Shera, F. Jawad, and A. Maqsood, “Prevalence of diabetes in Pakistan,” Diabetes Research and Clinical Practice, vol. 76, no. 2, pp. 219–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Akhtar and S. Rozi, “An autoregressive integrated moving average model for short-term prediction of hepatitis C virus seropositivity among male volunteer blood donors in Karachi, Pakistan,” World Journal of Gastroenterology, vol. 15, no. 13, pp. 1607–1612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. E. Shaw, P. Z. Zimmet, D. McCarty, and M. De Courten, “Type 2 diabetes worldwide according to the new classification and criteria,” Diabetes Care, vol. 23, no. 2, pp. B5–B10, 2000. View at Google Scholar · View at Scopus
  12. C. Sarrazin, B. C. Gärtner, D. Sizmann et al., “Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5,” Journal of Clinical Microbiology, vol. 44, no. 3, pp. 729–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Antonelli, C. Ferri, S. M. Ferrari, M. Colaci, D. Sansonno, and P. Fallahi, “Endocrine manifestations of hepatitis C virus infection,” Nature Clinical Practice Endocrinology and Metabolism, vol. 5, no. 1, pp. 26–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. L. White, V. Ratziu, and H. B. El-Serag, “Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis,” Journal of Hepatology, vol. 49, no. 5, pp. 831–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Zhao, J.-B. Wang, and J. Jiao, “Investigation on the incidence of diabetes in chronic hepatitis C patients and their HCV genotypes,” Zhonghua Gan Zang Bing Za Zhi, vol. 14, no. 2, pp. 86–88, 2006. View at Google Scholar · View at Scopus
  16. B. Younas, G. M. Khan, and M. A. Chaudhary, “Prevalence of diabetes mellitus among patients suffering from chronic liver disease,” Mother and Child, vol. 38, no. 1, pp. 37–40, 2000. View at Google Scholar
  17. I. A. Shah, S. Shah, Z. Hayat, M. Noor, and M. Arshad, “Impaired glucose tolerance in HCV/HBV cirrhosis,” Journal of Postgraduate Medical Institute, vol. 14, no. 1, pp. 68–72, 2011. View at Google Scholar